![Jason Amello](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Amello
Director of Finance/CFO at
TSCAN THERAPEUTICS, INC.
Net worth: - $ as of 2026-05-30
Profile
Jason A. Amello is Chief Financial & Accounting Officer, Treasurer at TScan Therapeutics, Inc. since 2026.
Former roles include Director at Opexa Therapeutics, Inc.; Independent Director at Acer Therapeutics, Inc. from 2017 to 2023; Director at New England Baptist Hospital from 2015 to 2023; Senior Manager at Deloitte LLP (New York) from 1990 to 2000; Chief Financial Officer, Treasurer & Executive VP at Alaunos Therapeutics, Inc. in 2013; Treasurer, Chief Financial & Accounting Officer at Akebia Therapeutics, Inc. from 2013 to 2020; Chief Financial & Accounting Officer, Secretary at Candel Therapeutics, Inc. from 2022 to 2024; Chief Financial Officer at Saniona AB from 2020 to 2022; and Chief Accounting Officer, Senior VP & Controller at Genzyme Corp.
from 2000 to 2011.
Education includes undergraduate studies at Boston College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 0 ( -.--% ) | - $ | 2026-05-30 |
Jason Amello active positions
| Companies | Position | Start |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Director of Finance/CFO | 2024-01-28 |
Former positions of Jason Amello
| Companies | Position | End |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Director of Finance/CFO | 2024-01-11 |
| ACER THERAPEUTICS INC. | Director/Board Member | 2023-11-16 |
New England Baptist Hospital
 New England Baptist Hospital Hospital/Nursing ManagementHealth Services Provides healthcare services | Director/Board Member | 2022-12-31 |
| SANA AB | Director of Finance/CFO | 2022-03-31 |
| AKEBIA THERAPEUTICS, INC. | Director of Finance/CFO | 2020-06-28 |
Training of Jason Amello
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Deloitte LLP (New York)
 Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Provides audit, consulting, tax and financial advisory services | Commercial Services |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
 Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Health Technology |
New England Baptist Hospital
New England Baptist Hospital Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Saniona AB
 Saniona AB BiotechnologyHealth Technology Engages in the research and development of drugs to treat the central nervous system diseases | Health Technology |
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases | Health Technology |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
- Stock Market
- Insiders
- Jason Amello
